The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.

Context: Doxorubicin (DXR) is a common anticancer drug known to produce several complications. Terminalia chebula popularly known as ‘King of medicine’ is found to possess wound healing, anti-inflammatory and antioxidant properties. Aims: To evaluate the effects of Terminalia chebula extract on d...

Full description

Bibliographic Details
Main Authors: Aamina Muneer, Ahmad Alhowail, Maha Aldubayan, Syed Imam Rabbani
Format: Article
Language:English
Published: Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) 2020-05-01
Series:Journal of Pharmacy & Pharmacognosy Research
Subjects:
Online Access:http://jppres.com/jppres/pdf/vol8/jppres19.773_8.3.237.pdf
id doaj-ddf6903642ae4fefb2d11ce21f00d2e3
record_format Article
spelling doaj-ddf6903642ae4fefb2d11ce21f00d2e32020-11-25T00:37:32ZengAcademic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)Journal of Pharmacy & Pharmacognosy Research0719-42502020-05-0183237246The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.Aamina Muneer0Ahmad Alhowail1Maha Aldubayan2Syed Imam Rabbani3Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, India.Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah, Kingdom of Saudi Arabia.Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah, Kingdom of Saudi Arabia.Department of Pharmacology, Al-Ameen College of Pharmacy, Bangalore, India. Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraidah, Kingdom of Saudi Arabia.Context: Doxorubicin (DXR) is a common anticancer drug known to produce several complications. Terminalia chebula popularly known as ‘King of medicine’ is found to possess wound healing, anti-inflammatory and antioxidant properties. Aims: To evaluate the effects of Terminalia chebula extract on doxorubicin-induced renal damages in rats. Methods: Coadministration of Terminalia chebula extract (0.25, 0.5 and 1.0 g/kg) was tested against DXR (2.5 mg/kg) induced renal damages in rats. Additional two groups were evaluated by administering 0.5 g/kg of the extract to animals either before or after DXR treatment. Kidney function tests were performed by measuring the serum levels of urea, creatinine, uric acid, and total protein. The antioxidant activity of the extract was evaluated by in vivo and in vitro methods. Histopathology of kidney tissues was performed to assess the morphological changes. The significance of results obtained were statistically analyzed. Results: The data obtained indicated that co-administration of the extract at higher doses (0.5 and 1.0 g/kg) significantly (p<0.01) reduces the serum levels of creatinine, urea, uric acid, and total proteins compared to DXR group. The extract also decreases the structural damages induced by DXR and exhibited antioxidant property. However, the pre- and post-treatments of Terminalia extract neither alter significantly the biomarker levels nor ameliorated the histopathological changes induced by DXR in rats. Conclusions: The observations indicated that co-administration of Terminalia chebula decreased the renal damage induced by DXR in rats. The protective action of the extract may be related to its wound-healing and antioxidant properties, the latter of which diminished the free-radical damage induced by DXR.http://jppres.com/jppres/pdf/vol8/jppres19.773_8.3.237.pdfantioxidantdoxorubicinrenal damageterminalia chebula
collection DOAJ
language English
format Article
sources DOAJ
author Aamina Muneer
Ahmad Alhowail
Maha Aldubayan
Syed Imam Rabbani
spellingShingle Aamina Muneer
Ahmad Alhowail
Maha Aldubayan
Syed Imam Rabbani
The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.
Journal of Pharmacy & Pharmacognosy Research
antioxidant
doxorubicin
renal damage
terminalia chebula
author_facet Aamina Muneer
Ahmad Alhowail
Maha Aldubayan
Syed Imam Rabbani
author_sort Aamina Muneer
title The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.
title_short The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.
title_full The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.
title_fullStr The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.
title_full_unstemmed The activity of Terminalia chebula Retz. extract on doxorubicin-induced renal damage in rats.
title_sort activity of terminalia chebula retz. extract on doxorubicin-induced renal damage in rats.
publisher Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
series Journal of Pharmacy & Pharmacognosy Research
issn 0719-4250
publishDate 2020-05-01
description Context: Doxorubicin (DXR) is a common anticancer drug known to produce several complications. Terminalia chebula popularly known as ‘King of medicine’ is found to possess wound healing, anti-inflammatory and antioxidant properties. Aims: To evaluate the effects of Terminalia chebula extract on doxorubicin-induced renal damages in rats. Methods: Coadministration of Terminalia chebula extract (0.25, 0.5 and 1.0 g/kg) was tested against DXR (2.5 mg/kg) induced renal damages in rats. Additional two groups were evaluated by administering 0.5 g/kg of the extract to animals either before or after DXR treatment. Kidney function tests were performed by measuring the serum levels of urea, creatinine, uric acid, and total protein. The antioxidant activity of the extract was evaluated by in vivo and in vitro methods. Histopathology of kidney tissues was performed to assess the morphological changes. The significance of results obtained were statistically analyzed. Results: The data obtained indicated that co-administration of the extract at higher doses (0.5 and 1.0 g/kg) significantly (p<0.01) reduces the serum levels of creatinine, urea, uric acid, and total proteins compared to DXR group. The extract also decreases the structural damages induced by DXR and exhibited antioxidant property. However, the pre- and post-treatments of Terminalia extract neither alter significantly the biomarker levels nor ameliorated the histopathological changes induced by DXR in rats. Conclusions: The observations indicated that co-administration of Terminalia chebula decreased the renal damage induced by DXR in rats. The protective action of the extract may be related to its wound-healing and antioxidant properties, the latter of which diminished the free-radical damage induced by DXR.
topic antioxidant
doxorubicin
renal damage
terminalia chebula
url http://jppres.com/jppres/pdf/vol8/jppres19.773_8.3.237.pdf
work_keys_str_mv AT aaminamuneer theactivityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT ahmadalhowail theactivityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT mahaaldubayan theactivityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT syedimamrabbani theactivityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT aaminamuneer activityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT ahmadalhowail activityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT mahaaldubayan activityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
AT syedimamrabbani activityofterminaliachebularetzextractondoxorubicininducedrenaldamageinrats
_version_ 1725300778234544128